Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1999
08/26/1999WO1999025391A3 Biodegradable polymer scaffold
08/26/1999WO1999024462A3 Novel conjugates of rgd-containing peptides and endogenous carriers
08/26/1999WO1999018973A3 Liquid presentations of oxazaphosphorine-containing pharmaceutical products
08/26/1999DE19808634A1 Production of pharmaceutical pellets, especially containing iloprost, with stabilized release properties
08/26/1999DE19807979A1 New water-soluble dendrimeric fullerene derivatives, useful as neuroprotective and radical scavenging drugs
08/26/1999CA2321966A1 Method for producing a liquid enriched with ingredients and active agents of plants using a carrier and storage material for plants and their active agents, liquids therefrom, andtheir use as cosmetic, therapeutic and cleaning agent
08/26/1999CA2321296A1 Composition and method for the treatment of bladder cancer
08/26/1999CA2321262A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
08/26/1999CA2321102A1 Regulation of estrus and ovulation in gilts
08/26/1999CA2320772A1 High-energy cyclodextrin complexes
08/26/1999CA2309943A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
08/25/1999EP0937755A1 Precipitated silica granules
08/25/1999EP0937456A1 Erythropoietin liposomal dispersion
08/25/1999EP0937148A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
08/25/1999EP0936913A1 Oral pharmaceutical preparation containing ibandronat
08/25/1999EP0936905A1 Immediate wettability water soluble film or water soluble layer for oral application
08/25/1999EP0936902A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
08/25/1999EP0936901A1 Pharmaceutical composition for rapid suspension in aqueous media
08/25/1999EP0783482A4 Cationic transport reagents
08/25/1999EP0766661B1 Polyolpolyhydroxystearates
08/25/1999EP0700290B1 Rectal compositions containing odansetron in its free base form
08/25/1999EP0572494B1 Composition for use in transdermal administration
08/25/1999CN1226927A Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
08/25/1999CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof
08/25/1999CN1226842A Preservation by foam formation
08/25/1999CN1226835A -i gene transfer methods for wound healing
08/25/1999CN1226834A Use of (meth) acrylic acid copolymers to increase permeability of mucous membranes
08/25/1999CN1226821A Microparticles
08/25/1999CN1226584A The production of solid dosage forms
08/25/1999CN1226583A The production of solid dosage forms
08/24/1999US5942620 Methods for producing novel conjugates of thrombin inhibitors
08/24/1999US5942602 Growth factor receptor antibodies
08/24/1999US5942550 Cholesterol lowering drink mix compositions
08/24/1999US5942545 Composition and method for treating penile erectile dysfunction
08/24/1999US5942508 Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
08/24/1999US5942501 Cyclodextrin derivative complex
08/24/1999US5942498 Formulations containing hyaluronic acid
08/24/1999US5942496 Methods and compositions for multiple gene transfer into bone cells
08/24/1999US5942253 Prolonged release of GM-CSF
08/24/1999US5942251 Pharmaceutical compositions for intranasal administration of dihydroergotamine
08/24/1999US5942250 Compositions and methods for enhancing the topical effects of sunscreen agents
08/24/1999US5942249 Improved dissolution and absorption of antiplatelet agents, heart stimulants, vasodilator, antagonists, thromboxane synthetase inhibitor
08/24/1999US5942248 Pharmaceutical composition containing a low detergent effect bile salt and an active compound that undergoes biliary excretion and/or enterohepatic recycling
08/24/1999US5942245 Application of SOD in liposomes
08/24/1999US5942243 Mucoadhesive compositions for administration of biologically active agents to animal tissue
08/24/1999US5942242 Medicaments for nasal administration
08/24/1999US5942241 A sustained release drug containing a substrate comprising a local anesthetic and a biocompatible, biodegradable, controlled release polymer selected from polyanhydrides, lactic acid and glycolic acid homo-or/and copolymers
08/24/1999US5942239 A fast-drying skin protectant comprising polyetherurethane copolymer, benzoin gum and solvent providing a dry film that is elastic, vapor permeable, water proof, dirt proof, insect proof, aerobic bacteriostatic, and adheres well to skin
08/24/1999US5942237 Pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane
08/24/1999US5942233 Herbal composition for stimulating blood circulation
08/24/1999US5942230 Composition of immunotoxins and retinoids and use thereof
08/24/1999US5942213 Polyethersiloxane cosmetic blend
08/24/1999US5942210 Methods for lyoprotecting a macromolecule using tricine
08/24/1999US5942209 Polymerizing a biodegradable, biocompatible polymer vehicle, e.g. epoxide-containing polymer, polyester, polyurethane, polyamide, polysulfone or an addition polymer, containing radionuclides; drug delivery
08/24/1999CA2009065C Use of solutions of atelocollagen and polyholosides, for example glycosaminoglycans, for the manufacture of microcapsules, microcapsules produced in this way, processes for the manufacture of such microcapsules and cosmetic, pharmaceutical or food compositions in which they are present
08/19/1999WO1999041341A1 Use of detergent mixtures as solutizers
08/19/1999WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999WO1999040944A2 Hydroxylation activated drug release
08/19/1999WO1999040921A2 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
08/19/1999WO1999040920A1 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
08/19/1999WO1999040918A1 Morphine sulphate microgranules, method for making same and pharmaceutical preparations
08/19/1999WO1999040909A1 Method for modulating macrophage activation
08/19/1999WO1999040789A1 Methods and compounds for the genetic treatment of hyperlipidemia
08/19/1999WO1999040771A2 Concurrent flow mixing for preparing compositions comprising gene therapy vectors
08/19/1999WO1999030741A3 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
08/19/1999WO1999030694A3 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
08/19/1999WO1999025322A3 Pharmaceutical compositions having the shape of powders of cross-linked polymers loaded with drugs and related preparation process by supercritical fluids
08/19/1999WO1999024448A3 New sophoroselipids, method for their production and use
08/19/1999WO1999024076A3 Salicylate derivatized therapeutic and diagnostic agents
08/19/1999WO1999024074A3 Novel conjugates of opioids and endogenous carriers
08/19/1999WO1999020256A3 Medicament excipient particles for tissue-specific application of a medicament
08/19/1999WO1999016419A9 Perforated microparticles and methods of use
08/19/1999WO1999016412A3 Non-irritating cosmetic and pharmaceutical compositions
08/19/1999WO1999015210B1 Bioadhesive compositions and methods for topical administration of active agents
08/19/1999WO1999012570A3 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
08/19/1999WO1998028010A3 Use of moieties for binding to hyaluronan and icam-1
08/19/1999WO1998020094A3 Compositions for disinfection of skin and mucous membrane
08/19/1999WO1998008966A8 Loxoprofen-containing preparation for external use
08/19/1999WO1997003655A8 Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
08/19/1999DE19859526A1 Pharmaceutical composition, especially for gene transfer and therapy
08/19/1999CA2632106A1 Method for modulating macrophage activation
08/19/1999CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999CA2320965A1 Methods and compounds for the genetic treatment of hyperlipidemia
08/19/1999CA2319740A1 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
08/18/1999EP0935651A2 THERAPY FOR $g(a)-GALACTOSIDASE A DEFICIENCY
08/18/1999EP0935631A2 Grafted rubber-like silicone gel with enhanced oil compatibility and its synthetic process
08/18/1999EP0935613A1 Acylated cyclodextrin derivatives
08/18/1999EP0935471A1 Mononuclear phagocytes in therapeutic drug delivery
08/18/1999EP0935454A1 Cosmetic and/or pharmaceutical preparations
08/18/1999EP0935417A1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
08/18/1999EP0935415A1 Methods for delivering compounds into a cell
08/18/1999EP0789715A4 Complementarily bonded two- and three-dimensional supramolecular structures
08/18/1999EP0766556B1 Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use
08/18/1999EP0756489B1 Cyclosporin containing composition and process for the preparation thereof
08/18/1999EP0651799B1 Fibrin binding domain polypeptides and uses and methods of producing same
08/18/1999EP0642334B1 Pharmaceutical and other dosage forms
08/18/1999CN1226253A Steroid bisphosphonates
08/18/1999CN1226176A Polypeptides having single covalently bound N-terminal water-soluble polymer
08/18/1999CN1226175A Sorbefaccients
08/17/1999US5939485 Responsive polymer networks and methods of their use
1 ... 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 ... 1712